117th Congress (2021–2023) · House bill · Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
This page covers HR4369 in the 117th Congress. Bill numbers start over every Congress, so HR4369 in another Congress is a different bill.
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | House |
| Latest vote | 2021-10-19: Passed |
| Latest action | 2021-10-20: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| Policy area | Health |
| Official record | Congress.gov |
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Subjects: Advanced technology and technological innovations, Congressional oversight, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Food and Drug Administration (FDA), Government information and archives, Health programs administration and funding, Health technology, devices, supplies, Higher education, Manufacturing
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2021-10-19 | House | 2/3 Yea-And-Nay | Passed | 250 | 37 | 5 | Official tally |
HR4369 (National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021) was introduced in the 117th Congress (2021–2023) by Rep. Pallone, Frank, Jr. [D-NJ-6].
On 2021-10-20: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
1 recorded vote in the 117th Congress. The most recent, on 2021-10-19, was "2/3 Yea-And-Nay": Passed.